Exosome Industry Biotech Report 2022
Summary
In this report, we describe 45 companies (see below) that have emerged over the last decade to pursue exosome therapeutics and diagnostic goals. Two tables provide a quick reference with information on investor funding and founding date. A further table provides a summary of 242 exosome-focused clinical trials.
Download the report
Exosome Therapeutic and Diagnostic Companies Covered
Therapeutics |
Diagnostics |
|
Adipomics |
Biological Dynamics |
|
Aegle Therapeutics |
ExosomeDx |
|
Aethlon Medical |
Exosome Plus |
|
Anjarium Biosciences |
Exosome Sciences |
|
Aruna Bio |
Exosomics |
|
Avalon Globocare |
NanoSomix |
|
BrainStorm Cell Therapeutics |
Nanostics |
|
Capricor Therapeutics |
Oasis Diagnostics |
|
Carmine Therapeutics |
Sienna Diagnostics |
|
Ciloa |
Theoria Science |
|
Codiak BioSciences |
|
|
Creative Medical Technology |
|
|
Direct Biologics |
|
|
Divide and Conquer |
|
|
Evox Therapeutics |
|
|
ExoCoBio |
|
|
Exopharm |
|
|
Ilias Biologics |
|
|
Innocan Pharma |
|
|
Kimera Labs |
|
|
MantraBio |
|
|
MDimune |
|
|
Neurexo Sciences |
|
|
OmniSpirant |
|
|
Organicell |
|
|
Puretech Health |
|
|
ReNeuron |
|
|
Stem Cell Medicine, Ltd. |
|
|
TAVEC Pharmaceuticals |
|
|
The Cell-Factory |
|
|
Unicyte |
|
|
Versatope |
|
|
Vesvigen Therapeutics |
|
|
VivaZome Therapeutics |
|
|
XOStem Inc. |
|
|
Learn more about powerful technologies that are enabling research: